In the SURPASS clinical trial program for type 2 diabetes, patients achieved HbA1c reductions of 1.9% to 2.6% depending on dose, with weight loss averaging 15-22 pounds across studies
Texas residents trust our commitment to safe and effective solutions
Although GLP-1 medications have been around for decades as diabetes drugs, they have only recently been approved for weight loss by the Federal Drug Administration (FDA), and thats what has led to a significant increase in popularity and a rise in microdosing them
Science-backed formulation May help curb post-meal glucose spikes Vegetarian and non-GMO Expensive Research is still limited Requires refrigeration Formulation Glucose Control is built around a five-strain probiotic blend plus a prebiotic fiber, making it technically a synbiotic, not a probiotic alone
The Mounjaro three month results breakdown gives a practical sense of what tirzepatide produces in the early months of treatment, which can help set realistic expectations